Dotquant specializes in developing advanced imaging tools and biologics for cancer and neurological disorders. Our unique and proprietary platform offers a complete solution to the screening and validation of drug candidates, low-cost synthesis of stable and long-circulating biologics especially aptamers, and targeted delivery. We welcome academic and industry partners for drug development projects and clinical trials.